申请人:E. R. Squibb & Sons, Inc.
公开号:US03976660A1
公开(公告)日:1976-08-24
Pyrrolidine derivatives which have the formula ##SPC1## Wherein R and R.sub.1 each is hydrogen, --(CH.sub.2).sub.6 COOH, --(CH.sub.2).sub.6 COO-- lower alkyl, or --(CH.sub.2).sub.6 COO benzyl and R.sub.2 is hydrogen, --CO--O--(CH.sub.2).sub.5 CH.sub.3, --CO--NH--(CH.sub.2).sub.5 CH.sub.3 --(CH.sub.2).sub.7 CH.sub.3 or --CH=CH--CH(OH)--(CH.sub.2).sub.4 --CH.sub.3, at least one of R and R.sub.1 is hydrogen and R.sub.1 and R.sub.2 are not both hydrogen, are new compounds which are useful as inhibitors of prostaglandin dehydrogenase and as potentiators of prostaglandin activity.
具有以下式子的吡咯烷衍生物 ##SPC1## 其中R和R.sub.1分别是氢,--(CH.sub.2).sub.6 COOH,--(CH.sub.2).sub.6 COO-较低烷基,或--(CH.sub.2).sub.6 COO苄基,R.sub.2是氢,--CO--O--(CH.sub.2).sub.5 CH.sub.3,--CO--NH--(CH.sub.2).sub.5 CH.sub.3--(CH.sub.2).sub.7 CH.sub.3或--CH=CH--CH(OH)--(CH.sub.2).sub.4--CH.sub.3,其中至少一个是氢,且R.sub.1和R.sub.2不同时为氢。这些新化合物可用作前列腺素脱氢酶抑制剂和前列腺素活性增强剂。